Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom-Soo Shin

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|November 12, 2010
Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modelingBeom Soo Shin, Jürgen B Bulitta, Joseph P Balthasar, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2009
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapyDhaval K Shah, Beom Soo Shin, Jean Veith, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
In vitro investigation of the hepatic intrinsic clearance of apicidin, a histone deacetylase inhibitor, in mouse, rat, and human, with correction by nonspecific protein bindingBeom Soo Shin, Eun Hye Park, Chi Ho Yoon, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 8, 2017
HPLC-MS/MS analysis of mesupron and its application to a pharmacokinetic study in ratsChangmin Park, Joong Gyu Ha, Seungmok Choi, et al.
Chemosphere|January 23, 2022
Comparison of the exposure assessment of di(2-ethylhexyl) phthalate between the PBPK model-based reverse dosimetry and scenario-based analysis: A Korean general population studyHyojung Yoon, Tae Hwan Kim, Byoung-Cheun Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2022
Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositionsJun Young Lim, Tae Hwan Kim, Chang Ho Song, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
Altered oral absorption of alcohol by combined aqueous extracts of four herbal plants in ratsBeom Soo Shin, Hun Jun, Dong-Eok Lee, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo[a]pyrene and 3-OH-benzo[a]pyrene in ratsDianxiu Cao, Chi Ho Yoon, Beom Soo Shin, et al.
International Journal of Pharmaceutics|January 11, 2017
Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxelHima Bindu Ruttala, Thiruganesh Ramasamy, Beom Soo Shin, et al.
Molecular Pharmaceutics|November 5, 2016
Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage FormulationTae Hwan Kim, Soyoung Shin, Jürgen B Bulitta, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|November 12, 2010
Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modelingBeom Soo Shin, Jürgen B Bulitta, Joseph P Balthasar, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2009
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapyDhaval K Shah, Beom Soo Shin, Jean Veith, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
In vitro investigation of the hepatic intrinsic clearance of apicidin, a histone deacetylase inhibitor, in mouse, rat, and human, with correction by nonspecific protein bindingBeom Soo Shin, Eun Hye Park, Chi Ho Yoon, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 8, 2017
HPLC-MS/MS analysis of mesupron and its application to a pharmacokinetic study in ratsChangmin Park, Joong Gyu Ha, Seungmok Choi, et al.
Chemosphere|January 23, 2022
Comparison of the exposure assessment of di(2-ethylhexyl) phthalate between the PBPK model-based reverse dosimetry and scenario-based analysis: A Korean general population studyHyojung Yoon, Tae Hwan Kim, Byoung-Cheun Lee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2022
Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositionsJun Young Lim, Tae Hwan Kim, Chang Ho Song, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
Altered oral absorption of alcohol by combined aqueous extracts of four herbal plants in ratsBeom Soo Shin, Hun Jun, Dong-Eok Lee, et al.
Journal of Toxicology and Environmental Health. Part A|December 6, 2005
Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo[a]pyrene and 3-OH-benzo[a]pyrene in ratsDianxiu Cao, Chi Ho Yoon, Beom Soo Shin, et al.
International Journal of Pharmaceutics|January 11, 2017
Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxelHima Bindu Ruttala, Thiruganesh Ramasamy, Beom Soo Shin, et al.
Molecular Pharmaceutics|November 5, 2016
Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage FormulationTae Hwan Kim, Soyoung Shin, Jürgen B Bulitta, et al.
Pageof 16